首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1957051

日本兒童醫療保健市場規模、佔有率、趨勢和預測：按類型、治療方法和地區分類，2026-2034年

Japan Pediatric Healthcare Market Size, Share, Trends and Forecast by Type, Treatment, and Region, 2026-2034

出版日期: 2026年02月01日 | 出版商:

IMARC | 英文 150 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本兒童醫療保健市場規模達8.273億美元。 IMARC Group預測，到2034年，該市場規模將達到12.087億美元，2026年至2034年的複合年成長率（CAGR）為4.30%。市場成長顯著的原因包括：人們對兒童疾病的認知不斷提高、兒童治療技術的進步以及政府為改善兒童醫療保健服務所採取的措施。兒童慢性病和心理健康問題的日益增加也加速了對專業醫療服務的需求。隨著醫療基礎設施的不斷完善和預防措施的日益重視，預計日本兒童醫療保健市場佔有率將繼續成長。

日本兒童醫療保健市場趨勢：

老化的影響

隨著日本人口老化，人們對兒童發展和長期健康管理的關注度日益提高，兒童醫療服務需求也隨之成長。隨著老年人口的不斷增加，政府和醫療體係正著力於早期診斷和預防，以應對未來的健康挑戰。為因應這些趨勢，近期推出的法律改革旨在支持家庭，並保障兒童的健康未來。例如，2024年6月，日本國會通過立法，擴大了兒童津貼和育嬰假的覆蓋範圍，以應對出生率下降的問題，並建立更公平的扶持體系。自10月起，享有這些福利的年齡將提高至18歲，育嬰假福利也將隨之提高，以減輕經濟負擔對建立家庭的影響。兒童醫學如今已成為保障下一代健康綜合策略的重要組成部分，不僅關注眼前的醫療需求，也致力於長期的健康促進。這包括對兒童疾病早期療育，以及倡導健康的生活方式以對抗肥胖和糖尿病。此外，隨著人們對發展障礙和兒童心理健康問題的認知不斷提高，對專業醫療服務的需求也不斷成長。在此背景下，日本老化社會間接催生了對更完善、更具前瞻性的兒童醫療基礎設施的需求，從而推動了日本兒童醫療市場的成長。

兒童醫學進展

兒童醫學的進步在滿足兒童獨特的健康需求方面發揮著至關重要的作用。針對不同年齡層的特效藥物和治療方法的研發正在改善年輕患者的治療效果。與成人不同，兒童對藥物的生理反應存在差異，因此，針對不同年齡的藥物配方對於確保療效和安全性至關重要。目前正在研發的新藥旨在更精準地治療兒童常見疾病，如氣喘、糖尿病和癲癇，並減少副作用。例如，2025年3月，日本新藥株式會社在日本推出了用於治療兒童肺動脈高壓（PAH）的口服藥物「UpTravi 0.05mg片劑」。這種口服藥物滿足了兒童治療領域的關鍵需求，此前兒科治療僅限於注射劑。該公司將繼續致力於開發針對罕見疾病的創新解決方案，並改善患者照護。此外，針對遺傳性疾病和發育障礙的兒童特效治療方法和疫苗也日益受到關注。非侵入性診斷技術的快速發展，包括用於監測兒童健康的穿戴式設備，也使得更及時、更精準的介入成為可能。兒童醫療保健領域的這些進步不僅改善了治療效果，也確保了兒童能夠獲得根據其個人需求量身定做的最佳護理，從而對日本兒童醫療保健市場產生了重大影響。

本報告解答的主要問題

日本兒童醫療保健市場迄今為止的發展如何？預計未來幾年將如何發展？
日本兒童醫療保健市場按類型是如何細分的？
日本兒童醫療保健市場按治療方法是如何分類的？
日本兒童醫療保健市場按地區分類的組成是怎樣的？
日本兒童醫療保健市場價值鏈的不同階段有哪些？
日本兒童醫療保健市場的主要促進因素和挑戰是什麼？
日本兒童醫療保健市場的結構是怎麼樣的？主要參與者有哪些？
日本兒童醫療保健市場的競爭程度如何？

The Japan pediatric healthcare market size reached USD 827.3 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 1,208.7 Million by 2034 , exhibiting a growth rate (CAGR) of 4.30 % during 2026-2034 . The market is experiencing significant growth due to a growing focus on childhood diseases, advancements in pediatric treatments, and government initiatives to improve child healthcare access. The increasing prevalence of chronic conditions and mental health concerns among children is also escalating the demand for specialized care. With enhanced healthcare infrastructure and a focus on preventive measures, the Japan pediatric healthcare market share is further poised for continued growth.

JAPAN PEDIATRIC HEALTHCARE MARKET TRENDS:

Aging Population Impact

Japan's aging population is driving a growing need for pediatric healthcare services, with increased focus on child development and long-term health management. As the elderly population rises, the government and healthcare systems are emphasizing early diagnosis and prevention to manage future health challenges. In response to these dynamics, recent legislative changes aim to support families and ensure a healthier future for children. For instance, in June 2024, Japan's parliament passed a law to increase child allowances and parental leave in response to the country's declining birthrate, aiming for equitable support. Starting in October, coverage will be extended to age 18, and benefits for childcare leave will increase amidst concerns about financial barriers impacting family growth. Pediatric care is now seen as part of the broader strategy to ensure a healthier next generation, addressing not only immediate healthcare needs but also fostering long-term well-being. This includes early interventions for childhood diseases and the promotion of healthier lifestyles to combat issues like obesity and diabetes. Additionally, a growing awareness of developmental disorders and mental health concerns in children has led to an increased demand for specialized care. As a result, the aging demographic has indirectly shaped the demand for a more robust and future-ready pediatric healthcare infrastructure in Japan, contributing to Japan pediatric healthcare market growth.

Advances in Pediatric Medicine

Advances in pediatric medicine are playing a crucial role in addressing the unique health needs of children. The development of specialized, age-appropriate medications and treatment methods has improved care outcomes for young patients. Unlike adults, children have different physiological responses to medications, making age-specific formulations essential for efficacy and safety. New medications are being developed to treat common pediatric conditions like asthma, diabetes, and epilepsy with higher precision and fewer side effects. For instance, in March 2025, Nippon Shinyaku Co., Ltd. launched Uptravi 0.05 mg tablets in Japan for treating pediatric pulmonary arterial hypertension (PAH). This oral medication addresses a significant need for pediatric treatments, previously limited to injectables. The company continues to focus on developing innovative solutions for rare diseases and enhancing patient care. Moreover, pediatric-specific treatments and vaccines for genetic and developmental disorders are increasingly receiving attention. Rapid progress in non-invasive diagnostic technologies, including wearables for monitoring the health of children, is also making interventions timelier and more precise. Such pediatric advances in medicine not only increase treatment efficacy but also ensure that children get the best care possible, specific to their needs, and have a strong influence on the Japan pediatric healthcare market.

JAPAN PEDIATRIC HEALTHCARE MARKET SEGMENTATION:

Type Insights:

Chronic Illness
Acute Illness

Treatment Insights:

Vaccines
Drugs
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region

The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT

How has the Japan pediatric healthcare market performed so far and how will it perform in the coming years?
What is the breakup of the Japan pediatric healthcare market on the basis of type?
What is the breakup of the Japan pediatric healthcare market on the basis of treatment?
What is the breakup of the Japan pediatric healthcare market on the basis of region?
What are the various stages in the value chain of the Japan pediatric healthcare market?
What are the key driving factors and challenges in the Japan pediatric healthcare market?
What is the structure of the Japan pediatric healthcare market and who are the key players?
What is the degree of competition in the Japan pediatric healthcare market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Pediatric Healthcare Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Pediatric Healthcare Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Pediatric Healthcare Market - Breakup by Type

6.1 Chronic Illness
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Acute Illness
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)

7 Japan Pediatric Healthcare Market - Breakup by Treatment

7.1 Vaccines
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Drugs
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Others
- 7.3.1 Historical and Current Market Trends (2020-2025)
- 7.3.2 Market Forecast (2026-2034)

8 Japan Pediatric Healthcare Market - Breakup by Region

8.1 Kanto Region
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Breakup by Type
- 8.1.4 Market Breakup by Treatment
- 8.1.5 Key Players
- 8.1.6 Market Forecast (2026-2034)
8.2 Kansai/Kinki Region
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Breakup by Type
- 8.2.4 Market Breakup by Treatment
- 8.2.5 Key Players
- 8.2.6 Market Forecast (2026-2034)
8.3 Central/ Chubu Region
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Breakup by Type
- 8.3.4 Market Breakup by Treatment
- 8.3.5 Key Players
- 8.3.6 Market Forecast (2026-2034)
8.4 Kyushu-Okinawa Region
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Breakup by Type
- 8.4.4 Market Breakup by Treatment
- 8.4.5 Key Players
- 8.4.6 Market Forecast (2026-2034)
8.5 Tohoku Region
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Breakup by Type
- 8.5.4 Market Breakup by Treatment
- 8.5.5 Key Players
- 8.5.6 Market Forecast (2026-2034)
8.6 Chugoku Region
- 8.6.1 Overview
- 8.6.2 Historical and Current Market Trends (2020-2025)
- 8.6.3 Market Breakup by Type
- 8.6.4 Market Breakup by Treatment
- 8.6.5 Key Players
- 8.6.6 Market Forecast (2026-2034)
8.7 Hokkaido Region
- 8.7.1 Overview
- 8.7.2 Historical and Current Market Trends (2020-2025)
- 8.7.3 Market Breakup by Type
- 8.7.4 Market Breakup by Treatment
- 8.7.5 Key Players
- 8.7.6 Market Forecast (2026-2034)
8.8 Shikoku Region
- 8.8.1 Overview
- 8.8.2 Historical and Current Market Trends (2020-2025)
- 8.8.3 Market Breakup by Type
- 8.8.4 Market Breakup by Treatment
- 8.8.5 Key Players
- 8.8.6 Market Forecast (2026-2034)

9 Japan Pediatric Healthcare Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Products Offered
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Products Offered
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Products Offered
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Products Offered
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Products Offered
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Pediatric Healthcare Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis